Clinical characteristics and risk factors associated with bone erosion in patients with tophi
- PMID: 38438904
- DOI: 10.1186/s42358-023-00336-w
Clinical characteristics and risk factors associated with bone erosion in patients with tophi
Abstract
Introduction: If a large amount of urate crystals is deposited in a joint cavity for an extended period of time, bone erosion will occur and gradually cause skeletal muscle necrosis and joint deformity. The aim of this study was to describe the clinical characteristics and factors associated with bone erosion in gout patients with tophi.
Methods: A total of 210 gout patients with tophi were enrolled and divided into a bone erosion group (n = 135) and a non-bone erosion group (n = 75). Digital radiography (DR) was performed to detect bone erosion in the elbow, wrist, knee, ankle joints, interphalangeal and metatarsophalangeal joints. The clinical characteristics were recorded and compared between the two groups. Multivariate logistic regression analysis was conducted to explore the factors associated with bone erosion.
Results: Compared with the non-bone erosion group, the bone erosion group had an older age, longer disease duration of gout and tophi, higher level of serum creatinine (sCr), higher proportion of drinking history and ulceration, and a lower glomerular filtration rate (GFR). Univariate logistic regression analysis results showed that sex, age, body mass index (BMI), gout duration, tophi duration, GFR, white blood cell (WBC) count, sCr level, smoking history, drinking history, and presence of ulceration were associated with bone destruction. Multivariable logistic regression analysis results indicated that tophi duration, drinking history, ulceration and sCr were positively and independently related to bone erosion.
Conclusions: Tophi patients with bone erosion presented different clinical characteristics. Tophi duration, drinking history, ulceration and sCr were associated with bone erosion in gout patients with tophi.
Keywords: Bone erosion; Characteristic; Gout; Risk factors; Tophi.
© 2024. The Author(s).
Similar articles
-
Clinical characteristics and risk factors of ulceration over tophi in patients with gout.Int J Rheum Dis. 2019 Jun;22(6):1052-1057. doi: 10.1111/1756-185X.13581. Epub 2019 May 22. Int J Rheum Dis. 2019. PMID: 31119888
-
Risk factors of ultrasound-detected tophi in patients with gout.Clin Rheumatol. 2020 Jun;39(6):1953-1960. doi: 10.1007/s10067-020-04947-2. Epub 2020 Feb 15. Clin Rheumatol. 2020. PMID: 32062769
-
Relationship between urate within tophus and bone erosion according to the anatomic location of urate deposition in gout: A quantitative analysis using dual-energy CT volume measurements.Medicine (Baltimore). 2019 Dec;98(51):e18431. doi: 10.1097/MD.0000000000018431. Medicine (Baltimore). 2019. PMID: 31861011 Free PMC article.
-
Evidence review for surgical excision of tophi: Gout: diagnosis and management: Evidence review O.London: National Institute for Health and Care Excellence (NICE); 2022 Jun. London: National Institute for Health and Care Excellence (NICE); 2022 Jun. PMID: 36063468 Free Books & Documents. Review.
-
Clinical features of gout.Reumatismo. 2012 Jan 19;63(4):238-45. doi: 10.4081/reumatismo.2011.238. Reumatismo. 2012. PMID: 22303530 Review.
Cited by
-
Evaluation of Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Chronic Refractory Gout in the United States.Adv Ther. 2025 Jul;42(7):3173-3185. doi: 10.1007/s12325-025-03189-5. Epub 2025 May 8. Adv Ther. 2025. PMID: 40338486 Free PMC article.
-
Current Status of Gout Arthritis: Current Approaches to Gout Arthritis Treatment: Nanoparticles Delivery Systems Approach.Pharmaceutics. 2025 Jan 14;17(1):102. doi: 10.3390/pharmaceutics17010102. Pharmaceutics. 2025. PMID: 39861750 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical